Bioanalysis is gaining importance due to its vital role in the early development of biotech drugs. Our company's analytical services division can design and perform a range of bioanalytical services based on the needs of our customers. The services cover biomarker assays, large-molecule drug analysis, and small-molecule drug analysis.
Service Overview
Our company is experienced in custom method development to support sample analysis for all in vitro study types and many in vivo models. Utilizing triple quadrupole and QTrap mass spectrometers, we conduct LC-MS/MS analysis to increase productivity for sensitive and focused quantification of drug candidates or tagged substrates.
For a variety of tiny compounds in different matrices such as plasma, urine, bile, feces, and tissue homogenates, we are able to separate them using reverse-phase, ion-pair, and HILIC procedures.
We have a great deal of experience using mass spectrometry and high-resolution QToF to analyze metabolites and identify low-temperature and radiolabeled test materials. For tiny peptide drug candidates, we frequently provide structure elucidation, biotransformation assignments, method development, and bioanalytical services.
A team of seasoned experts with strong theoretical backgrounds and hands-on experience in experimental design, experimental execution, bioanalysis, and data analysis makes up our bioanalytical services department's staff.
Research Capabilities
We can provide biomarker assay services for pharmaceutical R&D personnel. Whether it is the early screening of a large number of biomarkers or the large-scale validation of biomarkers, you can find the right technology platform and services to meet your R&D needs at Chengdu Bioanalytical Department.
- Macromolecular Drug Bioassays
We can provide FDA/CFDA GLP-compliant large molecule drug bioanalytical services to support the screening and development of protein drugs, antibody drugs, vaccines, and biomarkers, as well as preclinical and clinical studies.
- Small Molecule Drug Bioassays
We can provide FDA/CFDA GLP-compliant small molecule drug bioanalysis services to support the screening and development of small molecule drugs, as well as preclinical and clinical studies.
Overall Solutions
| Project Name | Bioanalytical Services |
| Service Options | |
| Deliverables | Within agreed time, we will provide the summary to experiment data and conclusions, as well as a final experiment report. |
| Cycle | Decide according to your needs. |
Instrument Capability
Our company's analytical laboratories are equipped with advanced equipment and managed by information technology, and experimental studies comply with FDA/CFDA GLP standard requirements.
- Multiple AB Sciex API 3000 triple quadrupole, API 4000 QTrap, 4500 triple quadrupole and 5500 QTrap MS/MS systems
- Multiple Xevo TQ-S triple quadrupole
- Xevo G2-XS QTof/Tof
- LC-UV in-line for qualitative assessment
- Automated liquid handlers (Tecan) for sample preparation
Our company's bioanalysis service can be customized for your innovative scientific research. Each project needs to be evaluated before the corresponding analysis plan and price can be determined. If you want to know more about service prices or technical details, please feel free to contact us.
Related Services
It should be noted that our service is only used for research, not for clinical use.
